Saint-Ruf C, Nardeux P, Cebrian J, Lacasa M, Lavialle C, Cassingena R
UPR6, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Int J Cancer. 1989 Aug 15;44(2):367-72. doi: 10.1002/ijc.2910440230.
The human HBL-100 cell line harbours SV40 DNA integrated in tandem at a unique site. The SV40 T-antigen expressed in these cells is defective in a function essential to the replication of the viral genome. The integrated SV40 sequences were molecularly cloned in a bacteriophage, and a subclone (plasmid pSVHBI) containing a complete SV40 DNA was isolated. As compared to SV40 wild-type strain 776, sequence analysis of pSVHBI early region revealed the presence of several DNA alterations. Among these, a point mutation at position 3199, predicting a change at amino-acid 540 of arginine to isoleucine, was shown by marker rescue to be responsible for the deficiency of T-antigen. This novel mutation further delimits one of the T-antigen domains involved in SV40 DNA replication. Transfection experiments demonstrated that the transforming activity of the SV40 genome from HBL-100 cells is still preserved. Moreover, several transformed human cell clones thus obtained could be permanently established in culture.
人HBL - 100细胞系在一个独特位点含有串联整合的SV40 DNA。在这些细胞中表达的SV40 T抗原在病毒基因组复制所必需的功能上存在缺陷。整合的SV40序列被分子克隆到噬菌体中,并分离出一个包含完整SV40 DNA的亚克隆(质粒pSVHBI)。与SV40野生型菌株776相比,pSVHBI早期区域的序列分析揭示了存在几个DNA改变。其中,3199位的一个点突变预测精氨酸的第540位氨基酸会变为异亮氨酸,通过标记拯救表明该突变是T抗原缺陷的原因。这个新突变进一步界定了参与SV40 DNA复制的T抗原结构域之一。转染实验表明,来自HBL - 100细胞的SV40基因组的转化活性仍然保留。此外,由此获得的几个转化的人细胞克隆可以在培养中永久建立。